Pharmacists demonstrate tremendous expertise in drug counseling and dispensation, so it seems undeniable that they should play a prominent role in clinical research. After all, clinical trials are designed to establish the safety and efficacy of drugs: a pharmacist’s specialty. However, pharmacists are rarely consulted in clinical trials. To remedy this issue, Founder and CEO…
We’ll be attending the annual meeting of NCPA in Kansas City, October 1 – 4. If you’re coming, let’s meet up! Our team on site will also be available at the CPESN USA booth #541 in the Exhibit Hall on Sunday, October 2, 2022 and on Monday, October 3, 2022 between 12:30 – 3:30 pm…
Pharmacists demonstrate tremendous expertise in drug counseling and dispensation, so it seems undeniable that they should play a prominent role in clinical research. Surprisingly, their skill sets are rarely used in clinical trials. That’s why Founder and CEO Gerald Finken created RxE2, a community-based decentralized trial technology company spearheaded by pharmacists, offering primary stakeholders their…
Fargo, ND , June 2 2022 – RxE2 announces the appointment of David Stark as Senior Director of Business Development. In his role as senior director of business development, Mr. stark will be in charge of exploring new opportunities for expansion and partnerships for RxE2. “We were looking for an individual with a wide range…
Fargo, ND, June 1, 2022 – For the second year in a row RxE2, led by CEO and two-time USA Cycling Masters National Champion, Gerald Finken, supports the NorthStar Cycling Club. “Getting young adults involved in cycling is a wonderful way to build lifelong friendships, develop teamwork skills, and to provide a means to deal…
Welcome to our E2 Dispensing Webinar series. Over the next few weeks, we will release 8 episodes, introducing the E2 dispensing methodology and ecosystem to all. These webinars are aimed at everyone involved in clinical research and clinical trials. We will go into RxE2’s innovative and disruptive way of simplifying decentralized clinical trials and more specifically introducing…
By: Gerald E. Finken Originally posted on Linkedin In November 2021, McKinsey & Company published an interesting article on how to boost excellence and innovation in clinical supply chains that are relevant to today’s industry practices. What I found most compelling was how a best-in-class clinical supply chain could change and adapt to accommodate decentralized clinical trials (DCTs)…
By: Gerald E. Finken Originally posted on Linkedin Being a pharmacist has always given me a unique insight into healthcare, especially as my career took me into the packaging and labeling of clinical supplies. I was always able to think about the packaging and labeling of clinical supplies from a different perspective, both as a…
By: Gerald E. Finken The introduction of decentralized clinical trials (“DCTs”) into clinical research has, in recent years, focused on the use of technology and telehealth to improve the clinical trial experience for patients. The proponents of the DCT model have heralded it, and rightly so, with improving study recruitment, providing better patient diversity, and…
Do you know how state pharmacy regulations apply to investigational drugs and why clinical trials need a central-fill pharmacy? Check out this live discussion from November 10th, and get your questions answered! Gerald Finken was joined by Jeremy Faulks, Director of Specialty Pharmacy at Thrifty White, for a live discussion on Regulations for Investigational Drugs,…